Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

July 1, 2020
Open Access

Therapeutic Angiogenesis with Sound Waves

Annals of Vascular Diseases
Tomohiko Shindo, Hiroaki Shimokawa
July 2, 2020

eHealth Literacy Training Among Carers of Older People and People with Dementia: A Modified Delphi Survey

Studies in Health Technology and Informatics
Areti EfthymiouEvridiki Papastavrou
June 28, 2020
Open Access

Can nutrition support healthy cognitive ageing and reduce dementia risk?

BMJ : British Medical Journal
Amy JenningsAnne Marie Minihane
July 6, 2020
Review

A new look at brittle diabetes

Journal of Diabetes and Its Complications
Irl B Hirsch, Linda M Gaudiani
June 27, 2020
Open Access

Training the Workforce to Conduct Embedded Pragmatic Clinical Trials to Improve Care for People Living with Dementia and Their Caregivers

Journal of the American Geriatrics Society
Christopher M CallahanSusan L Mitchell
June 27, 2020

An agnostic reevaluation of the amyloid cascade hypothesis of Alzheimer's disease pathogenesis: The role of APP homeostasis

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Richard J CaselliGuojun Bu
July 1, 2020
Review

REM sleep behavior disorder (RBD)

Neurobiology of Disease
Michele T Hu
July 1, 2020

Family Caregiving at the End of Life and Hospice Use: A National Study of Medicare Beneficiaries

Journal of the American Geriatrics Society
Vedika KumarKatherine A Ornstein
July 6, 2020

Cognitive rehabilitation of patients with neurodegenerative diseases

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
O S Levin, A N Bogolepova
June 27, 2020
Open Access

Statistical Considerations for Embedded Pragmatic Clinical Trials in People Living with Dementia

Journal of the American Geriatrics Society
Heather G AlloreThomas G Travison
July 2, 2020

Differences in association of leisure time activities and cognition in a racially/ethnically diverse cohort of older adults: Findings from the KHANDLE study

Alzheimer's & Dementia : Translational Research & Clinical Interventions
Rachel L PetersonRachel Whitmer
June 28, 2020
Open Access

Imaging the aging brain: study design and baseline findings of the SENIOR cohort

Alzheimer's Research & Therapy
Alexa HaegerSENIOR team
July 4, 2020

Cognitive function has a stronger correlation with perceived age than with chronological age

Geriatrics & Gerontology International
Yumi Umeda-KameyamaMasahiro Akishita
June 28, 2020

Theory and practice of aging upon COVID-19 pandemic

Advances in Gerontology = Uspekhi Gerontologii
A G Golubev, A V Sidorenko
July 1, 2020
Review

Telomere length and oxidative stress variations in a murine model of Alzheimer's disease progression

The European Journal of Neuroscience
Katia Martínez-GonzálezPaola Garcia-delaTorre
June 27, 2020
Open Access

Dissemination and Implementation of Evidence-Based Dementia Care Using Embedded Pragmatic Trials

Journal of the American Geriatrics Society
Laura N GitlinJoseph E Gaugler
June 28, 2020

CSF biomarkers in Olmsted County: Evidence of 2 subclasses and associations with demographics

Neurology
Argonde C Van HartenRonald C Petersen

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

© 2020 Meta ULC. All rights reserved
/feed-previews/aging-epidemiology/a9c8dd1c-63f7-411f-9565-a289f8e64eeb